Dr. Daniel H. Buitrago, MD

Dr. Buitrago practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Buitrago's NPI, 1346539129, was assigned on April 1, 2011. Dr. Buitrago graduated from Colegio Mayor de Nuestra Señora del Rosario in 2005. Dr. Buitrago holds Florida license ME164958.

Dr. Buitrago's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Buitrago's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Buitrago is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buitrago practices, 2 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Buitrago's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Buitrago is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Dr. Buitrago's licenses on file in 2 states: Florida and Massachusetts.

CMS counts 33 Medicare patients who saw Dr. Buitrago in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 3.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buitrago's median patient age at 67, with 55% women.

In 2018, Dr. Buitrago wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $59 in total drug cost. In 2017, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Buitrago for performance year 2024, reported as part of a group. Dr. Buitrago accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary artery bypass graft (CABG): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Buitrago, published from 2010 to 2020. 2018 was the busiest year, with 3. The most frequent topics are Thyroid Neoplasms, Carcinoma, Papillary and Proto-Oncogene Proteins B-raf. Dr. Buitrago has published most often in Ann Surg Oncol. Dr. Buitrago's most frequent co-authors are Adnan Majid, MD, Seth Joshua Berkowitz and Roger J. Laham, MD.

CMS Open Payments shows 44 general payments to Dr. Buitrago from 10 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 77% of the total. Paragonix Technologies, Inc. paid the most, $6,000.

Dr. Buitrago graduated from Colegio Mayor de Nuestra Señora del Rosario in 2005.

Dr. Buitrago is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.